Feedback / Questions
risvodetinib (ABLi-148009) - ABLi Therapeutics
https://www.globenewswire.com/news-release/2026/01/27/3226463/0/en/ABLi-Therapeutics-Completes-Collaboration-Agreement-with-The-Michael-J-Fox-Foundation-to-include-Risvodetinib-in-Path-to-Prevention-Platform-Trial.html
Jan 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next